Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 59.25% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 17.24% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 59.35% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | -6.64% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | -8.41% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 18.33% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 13.91% |
| 10 | Insight Molecular Diagnostics | 172.60 Mn | 143.67 Mn | 15,000.00 | -25.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.44% |
| Dec 31, 2025 | 70.62% |
| Sep 30, 2025 | 65.56% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | 77.02% |
| Dec 31, 2024 | -47.83% |
| Sep 30, 2024 | 99.88% |
| Jun 30, 2024 | 99.97% |
| Mar 31, 2024 | -137,466.43% |
| Dec 31, 2023 | -100.11% |
| Sep 30, 2023 | -49,795.57% |
| Jun 30, 2023 | -72,035.14% |
| Mar 31, 2023 | 100.04% |
| Dec 31, 2022 | 120.32% |
| Sep 30, 2022 | 46.21% |
| Jun 30, 2022 | 36.65% |
| Mar 31, 2022 | -133.78% |
| Dec 31, 2021 | -398,641.95% |
| Sep 30, 2021 | 99.85% |
| Jun 30, 2021 | 99.89% |